American Academy of Pediatrics.
Immunization in special clinical
circumstances. In: Pickering
LK,ed.2003 Red Book: Report of
the Commitee on Infectious
Disease.26th ed. Elk Grove
Village, IL: 54
Clarke P, Powell PJ, Goldblatt
D, Robinson MJ. Effect of a
fourth Haemophilus influenzae
type b immunization in preterm
infants who received
dexamethasone for chronic lung
disease. Arch Dis Child Fetal
Neonatal 2003; 88: 58-61
D´Angio. Immunization of the
premature infant. Pediatr Infect
Dis J 1999; 18: 824-825
D´Angio CT, Maniscalo WM,
Pichichero ME. Immunologic
response of extremely premature
infants to tetanus, Haemophilus
influenzae and polio
immunizations. Pediatrics 1995;
96: 18-22
Khalak R, Pichichero ME, D´Angio
CT. Three-year follow-up of
vaccine response in extremely
premature infants. Pediatrics
1998; 101: 597-560
Kirman KI, Lofthus G, Pichichero
ME et al. Seven-year follow-up
of vaccine response in extremely
premature infants. Pediatrics
2002; 109: 498-504
Omeñaca F, Garcia-Sicilia J,
Boceta R, et al. Immunogencicity
of a combined DTPa-HBV-IPV/Hib
vaccine in preterm infants (<37
weeks) as a primary vaccination
course. 3 rd World Congress of
WSPID. Santiago, Chile, November
2002
Omeñaca F, Garcia-Sicilia J,
Boceta R, Sistiaga S, Lopez G,
García-Corbeira P.
Immunogencicity of a combined
DTPa-HBV-IPV/Hib hexavalente
vaccine in preterm infants after
primary and booster doses. ICCAC
Congress . Chicago (EE.UU.).
September 2003. Poster L-186a
Sanchez PJ, Laptook AR, Fisher
L, et al. Apnea after
immunization of preterm infants.
J Pediatr 1997; 130: 746-751
Saari TN and the Committee on
Infectious Diseases American
Academy of Pediatrics
Immunization of Preterm and Low
Birth Weight Infants Pediatrics
2003;112:193-198
Saliou P. Ajjan N, Guérin N
Efficacité et tolerance des
vaccinations chez les prématures
Arch Pédiatr 2002 ;9 :629-37
Slack MH, Schapira D, Thwaites
RJ et al. Immune response of
premature infants to
meningococcal serogroup C and
combined diphtheria-tetanus
toxoids-acellular
pertussis-Haemophilus influenzae
type b conjugate vaccines. J
Infect Dis 2001; 184: 1617-20
